How I treat CMV reactivation after allogeneic hematopoietic stem cell transplantation
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
How I treat CMV reactivation after allogeneic hematopoietic stem cell transplantation
Authors
Keywords
-
Journal
BLOOD
Volume 135, Issue 19, Pages 1619-1629
Publisher
American Society of Hematology
Online
2020-03-23
DOI
10.1182/blood.2019000956
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In vitro comparison of currently available and investigational antiviral agents against pathogenic human double-stranded DNA viruses: A systematic literature review
- (2019) Roy F. Chemaly et al. ANTIVIRAL RESEARCH
- The prognostic impact of the cytomegalovirus serostatus in patients with chronic hematological malignancies after allogeneic hematopoietic stem cell transplantation: a report from the Infectious Diseases Working Party of EBMT
- (2019) Martin Schmidt-Hieber et al. ANNALS OF HEMATOLOGY
- Use of Leflunomide for Treatment of Cytomegalovirus Infection in Recipients of Allogeneic Stem Cell Transplant
- (2019) Anant Gokarn et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Fast breakthrough of resistant cytomegalovirus during secondary letermovir prophylaxis in a hematopoietic stem cell transplant recipient
- (2019) Susanne Jung et al. BMC INFECTIOUS DISEASES
- Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7)
- (2019) Per Ljungman et al. LANCET INFECTIOUS DISEASES
- Potential Application of TALENs against Murine Cytomegalovirus Latent Infections
- (2019) Chen et al. Viruses-Basel
- New vaccines and antiviral drugs for cytomegalovirus
- (2019) Paul Griffiths JOURNAL OF CLINICAL VIROLOGY
- Maribavir for Preemptive Treatment of Cytomegalovirus Reactivation
- (2019) Johan Maertens et al. NEW ENGLAND JOURNAL OF MEDICINE
- Valganciclovir Pharmacokinetics in Patients Receiving Oral Prophylaxis Following Kidney Transplantation and Model-Based Predictions of Optimal Dosing Regimens
- (2018) Thomas Tängdén et al. CLINICAL PHARMACOKINETICS
- Assessing the risk of CMV reactivation and reconstitution of antiviral immune response post bone marrow transplantation by the QuantiFERON-CMV-assay and real time PCR
- (2018) Adalbert Krawczyk et al. JOURNAL OF CLINICAL VIROLOGY
- T-Track-CMV and QuantiFERON-CMV assays for prediction of protection from CMV reactivation in kidney transplant recipients
- (2018) Smaranda Gliga et al. JOURNAL OF CLINICAL VIROLOGY
- Quantiferon-Cytomegalovirus assay: A potentially useful tool in the evaluation of CMV-specific CD8+ T-cell reconstitution in pediatric hematopoietic stem cell transplant patients
- (2018) Bilio Paouri et al. PEDIATRIC TRANSPLANTATION
- Assessment of the T-SPOT.CMV interferon-γ release assay in renal transplant recipients: A single center cohort study
- (2018) Dimitrios Chanouzas et al. PLoS One
- Clinical validation of a novel enzyme-linked immunosorbent spot assay-based in vitro diagnostic assay to monitor cytomegalovirus-specific cell-mediated immunity in kidney transplant recipients: a multicenter, longitudinal, prospective, observational study
- (2018) Bernhard Banas et al. TRANSPLANT INTERNATIONAL
- Definitions of Resistant and Refractory Cytomegalovirus Infection and Disease in Transplant Recipients for Use in Clinical Trials
- (2018) Roy F Chemaly et al. CLINICAL INFECTIOUS DISEASES
- Maribavir for Refractory or Resistant Cytomegalovirus Infections in Hematopoietic-cell or Solid-organ Transplant Recipients: A Randomized, Dose-ranging, Double-blind, Phase 2 Study
- (2018) Genovefa A Papanicolaou et al. CLINICAL INFECTIOUS DISEASES
- The Ability of a Cytomegalovirus ELISPOT Assay to Predict Outcome of Low-Level CMV Reactivation in Hematopoietic Cell Transplant Recipients
- (2018) Lynn El Haddad et al. JOURNAL OF INFECTIOUS DISEASES
- A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation
- (2018) Francisco M. Marty et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation
- (2017) Ifigeneia Tzannou et al. JOURNAL OF CLINICAL ONCOLOGY
- Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT
- (2017) M Neuenhahn et al. LEUKEMIA
- Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
- (2017) Francisco M. Marty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Usefulness of Monitoring Cytomegalovirus-Specific Immunity by Quantiferon-CMV in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients
- (2017) Sae-Mi Lee et al. Annals of Laboratory Medicine
- Adjuvant and salvage therapy with leflunomide for recalcitrant cytomegalovirus infections in hematopoietic cell transplantation recipients: A case series
- (2016) Firas El Chaer et al. ANTIVIRAL RESEARCH
- Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
- (2016) P. Teira et al. BLOOD
- How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients
- (2016) F. El Chaer et al. BLOOD
- Are We There Yet? Impact of the First International Standard for Cytomegalovirus DNA on the Harmonization of Results Reported on Plasma Samples
- (2016) Jutta K. Preiksaitis et al. CLINICAL INFECTIOUS DISEASES
- Quantiferon CMV assay in allogenic stem cell transplant patients
- (2016) Patrizia Bono et al. JOURNAL OF CLINICAL VIROLOGY
- Viraemia, immunogenicity, and survival outcomes of cytomegalovirus chimeric epitope vaccine supplemented with PF03512676 (CMVPepVax) in allogeneic haemopoietic stem-cell transplantation: randomised phase 1b trial
- (2016) Ryotaro Nakamura et al. Lancet Haematology
- Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre-emptive therapy: a retrospective cohort study
- (2016) Margaret L Green et al. Lancet Haematology
- Efficacy and Safety of a Preemptive Antiviral Therapy Strategy Based on Combined Virological and Immunological Monitoring for Active Cytomegalovirus Infection in Allogeneic Stem Cell Transplant Recipients
- (2016) David Navarro et al. Open Forum Infectious Diseases
- Valganciclovir for the Prevention of Complications of Late Cytomegalovirus Infection After Allogeneic Hematopoietic Cell Transplantation
- (2015) Michael Boeckh et al. ANNALS OF INTERNAL MEDICINE
- Recent Advances in Cytomegalovirus: An Update on Pharmacologic and Cellular Therapies
- (2015) Michael Boeckh et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Preventing stem cell transplantation-associated viral infections using T-cell therapy
- (2015) Ifigeneia Tzannou et al. Immunotherapy
- Combination therapy for multidrug-resistant cytomegalovirus disease
- (2015) C. Stuehler et al. Transplant Infectious Disease
- Diagnosis and treatment of cytomegalovirus 2013
- (2014) Hermann Einsele et al. CURRENT OPINION IN HEMATOLOGY
- CMV Prophylaxis in Hematopoietic-Cell Transplantation
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Activity of Broad-Spectrum T Cells as Treatment for AdV, EBV, CMV, BKV, and HHV6 Infections after HSCT
- (2014) A. Papadopoulou et al. Science Translational Medicine
- Geno- and Phenotypic Characterization of Human Cytomegalovirus Mutants SelectedIn Vitroafter Letermovir (AIC246) Exposure
- (2013) Thomas Goldner et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cytomegalovirus diseases after hematopoietic stem cell transplantation: A mini-review
- (2013) Ella J. Ariza-Heredia et al. CANCER LETTERS
- T lymphocytes targeting native receptors
- (2013) Cliona M. Rooney et al. IMMUNOLOGICAL REVIEWS
- High Rate of Cytomegalovirus Drug Resistance Among Patients Receiving Preemptive Antiviral Treatment After Haploidentical Stem Cell Transplantation
- (2013) Einat Shmueli et al. JOURNAL OF INFECTIOUS DISEASES
- CMX001 to Prevent Cytomegalovirus Disease in Hematopoietic-Cell Transplantation
- (2013) Francisco M. Marty et al. NEW ENGLAND JOURNAL OF MEDICINE
- New algorithm for valganciclovir dosing in pediatric solid organ transplant recipients
- (2013) A. Åsberg et al. PEDIATRIC TRANSPLANTATION
- Clinical Assessment of Anti-Viral CD8+ T Cell Immune Monitoring Using QuantiFERON-CMV® Assay to Identify High Risk Allogeneic Hematopoietic Stem Cell Transplant Patients with CMV Infection Complications
- (2013) Siok-Keen Tey et al. PLoS One
- Efficacy of a Viral Load-Based, Risk-Adapted, Preemptive Treatment Strategy for Prevention of Cytomegalovirus Disease after Hematopoietic Cell Transplantation
- (2012) Margaret L. Green et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Fourth European Conference on Infections in Leukaemia (ECIL-4): Guidelines for Diagnosis and Treatment of Human Respiratory Syncytial Virus, Parainfluenza Virus, Metapneumovirus, Rhinovirus, and Coronavirus
- (2012) Hans H. Hirsch et al. CLINICAL INFECTIOUS DISEASES
- A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2012) Mohamed A Kharfan-Dabaja et al. LANCET INFECTIOUS DISEASES
- Human cytomegalovirus kinetics following institution of artesunate after hematopoietic stem cell transplantation
- (2011) Dana G. Wolf et al. ANTIVIRAL RESEARCH
- Intensive strategy to prevent CMV disease in seropositive umbilical cord blood transplant recipients
- (2011) F. Milano et al. BLOOD
- Cytopenias after day 28 in allogeneic hematopoietic cell transplantation: impact of recipient/donor factors, transplant conditions and myelotoxic drugs
- (2011) H. Nakamae et al. HAEMATOLOGICA
- Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial
- (2011) Francisco M Marty et al. LANCET INFECTIOUS DISEASES
- Maribavir and human cytomegalovirus—what happened in the clinical trials and why might the drug have failed?
- (2011) Francisco M Marty et al. Current Opinion in Virology
- Decreased Infections in Recipients of Unrelated Donor Hematopoietic Cell Transplantation from Donors with an Activating KIR Genotype
- (2010) Marcie Tomblyn et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Evidence for a Bidirectional Relationship between Cytomegalovirus Replication and acute Graft-versus-Host Disease
- (2010) Nathan Cantoni et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- An International Comparison of Current Strategies to Prevent Herpesvirus and Fungal Infections in Hematopoietic Cell Transplant Recipients
- (2010) Margaret Pollack et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Immune monitoring with iTAg MHC Tetramers for prediction of recurrent or persistent cytomegalovirus infection or disease in allogeneic hematopoietic stem cell transplant recipients: a prospective multicenter study
- (2010) J. W. Gratama et al. BLOOD
- Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation
- (2010) T. Feuchtinger et al. BLOOD
- Drug-resistant cytomegalovirus in transplant recipients: a French cohort study
- (2010) S. Hantz et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Incidence, Risk Factors, and Outcome of Cytomegalovirus Infection and Disease in Patients Receiving Prophylaxis with Oral Valganciclovir or Intravenous Ganciclovir after Umbilical Cord Blood Transplantation
- (2009) Pau Montesinos et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipients
- (2009) W. Zhou et al. BLOOD
- How we treat cytomegalovirus in hematopoietic cell transplant recipients
- (2009) M. Boeckh et al. BLOOD
- Valganciclovir as pre-emptive therapy for cytomegalovirus infection post-allogenic stem cell transplantation: implications for the emergence of drug-resistant cytomegalovirus
- (2009) T. Allice et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now